Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K
Cancer Therapies02:49

Cancer Therapies

8.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bam-readcount - rapid generation of basepair-resolution sequence metrics.

Journal of open source software·2026
Same author

Trientine for hypertrophic cardiomyopathy: a phase 2 trial.

European heart journal·2026
Same author

Automating neoantigen selection for personalized cancer vaccine design.

medRxiv : the preprint server for health sciences·2026
Same author

pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy design.

ArXiv·2026
Same author

Individualised N-terminal Pro-B-type Natriuretic Peptide Thresholds for the Diagnosis of Heart Failure: A Proof-of-Concept Study.

Cureus·2026
Same author

Long-read cDNA sequencing reveals novel isoforms and spliceosome-mutant-enriched transcripts in AML and MDS.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Oct 29, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.7K

HPV transcript expression affects cervical cancer response to chemoradiation.

Fiona J Ruiz1,2, Matthew Inkman1,3, Ramachandran Rashmi1

  • 1Department of Radiation Oncology.

JCI Insight
|July 13, 2021
PubMed
Summary

Persistent human papillomavirus (HPV) infection causes most cervical cancers. High E6*I and E6 viral RNA levels predict poor chemoradiation treatment outcomes, suggesting new biomarkers for cervical cancer therapy.

Keywords:
Cervical cancerOncologyRadiation therapy

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.7K
Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

9.8K

Related Experiment Videos

Last Updated: Oct 29, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.7K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.7K
Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

9.8K

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Persistent human papillomavirus (HPV) infection is a primary cause of cervical cancer.
  • Current guidelines do not mandate HPV testing for newly diagnosed cervical cancer patients.
  • HPV genotype influences treatment response, with non-HPV 16 genotypes often associated with poorer outcomes.

Purpose of the Study:

  • To investigate the role of HPV genotypes and viral gene expression in cervical cancer treatment response.
  • To identify novel biomarkers for predicting outcomes after chemoradiation treatment (CRT).
  • To elucidate the mechanisms by which HPV E6 and E6*I transcripts affect CRT resistance.

Main Methods:

  • Analysis of an institutional cohort (n=88) and The Cancer Genome Atlas data (n=304) for HPV genotypes and viral RNA expression.
  • RNA sequencing to quantify E6 and E6*I transcript levels.
  • In vitro studies to assess the impact of HPV E6/E6*I overexpression on CRT resistance via p53-p21 pathway.

Main Results:

  • Patients with non-HPV 16 genotypes showed worse survival outcomes after CRT.
  • Higher levels of HPV E6 and E6*I transcripts were observed in tumors with non-HPV 16 genotypes.
  • HPV E6*I transcript expression was identified as a novel predictive biomarker for CRT outcomes.
  • In vitro studies confirmed that E6 and E6*I overexpression induce CRT resistance through p53-p21 dependent mechanisms.

Conclusions:

  • HPV E6*I and E6 transcript expression levels are potential predictive biomarkers for chemoradiation efficacy in cervical cancer.
  • Patients with high E6*I and E6 expression may not benefit from standard CRT and could require alternative treatment strategies.
  • These findings open avenues for personalized treatment approaches in cervical cancer based on HPV viral gene expression.